1. Home
  2. EVER vs PCRX Comparison

EVER vs PCRX Comparison

Compare EVER & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo EverQuote Inc.

EVER

EverQuote Inc.

HOLD

Current Price

$24.81

Market Cap

929.5M

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.06

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVER
PCRX
Founded
2008
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
929.5M
1.0B
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
EVER
PCRX
Price
$24.81
$25.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$33.00
$32.86
AVG Volume (30 Days)
330.6K
870.9K
Earning Date
02-23-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
284.14
N/A
EPS
1.44
0.47
Revenue
$644,656,000.00
$716,791,000.00
Revenue This Year
$36.72
$6.24
Revenue Next Year
$13.63
$9.53
P/E Ratio
$17.59
$53.26
Revenue Growth
57.83
3.14
52 Week Low
$17.20
$18.17
52 Week High
$30.03
$27.64

Technical Indicators

Market Signals
Indicator
EVER
PCRX
Relative Strength Index (RSI) 38.12 48.17
Support Level $26.45 $24.20
Resistance Level $27.47 $26.81
Average True Range (ATR) 0.79 1.02
MACD -0.37 -0.23
Stochastic Oscillator 15.99 26.35

Price Performance

Historical Comparison
EVER
PCRX

About EVER EverQuote Inc.

EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: